Literature DB >> 20602633

Cardiovascular dysautonomia in de novo Parkinson's disease without orthostatic hypotension.

H Oka1, C Toyoda1, M Yogo1, S Mochio1.   

Abstract

BACKGROUND: Clinical symptoms of Parkinson's disease (PD) include not only motor distress, but also autonomic dysfunction.
OBJECTIVE: To study the characteristics of subclinical autonomic nervous dysfunction in de novo PD without orthostatic hypotension (OH).
METHODS: Autonomic nervous function including cardiac sympathetic gain was evaluated on the basis of cardiac radioiodinated metaiodobenzylguanidine (MIBG) uptake, the response to the Valsalva maneuver, and spectral analyses of the RR interval and blood pressure in 20 patients with de novo PD without OH.
RESULTS: Decreased cardiac MIBG uptake was found even in patients with PD without OH. Hemodynamic studies using the Valsalva maneuver revealed that patients with PD without OH had preserved baroreceptor reflex sensitivity in phase II and phase IV. Blood pressures normally responded in early and late phase II, but not in phase IV. Blood pressure recovery time was slightly reduced in patients with PD without OH when compared with the value in controls. The low frequency component of the RR interval and systolic blood pressure and the ratio of RR-LF to RR-HF in de novo PD without OH were significantly reduced when compared with the control values, whereas the high frequency component of the RR interval did not differ significantly.
CONCLUSION: These results show that latent cardiac and vasomotor sympathetic dysfunction but not parasympathetic dysfunction is already present in early stage de novo PD, even without orthostatic hypotension.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20602633     DOI: 10.1111/j.1468-1331.2010.03135.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  16 in total

Review 1.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 2.  Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Authors:  Matthias Löhle; Carl-Johan Ramberg; Heinz Reichmann; Anthony H V Schapira
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

3.  Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.

Authors:  Yehonatan Sharabi; David S Goldstein
Journal:  J Neurol Sci       Date:  2011-07-16       Impact factor: 3.181

4.  Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease.

Authors:  Tadashi Umehara; Hiromasa Matsuno; Chizuko Toyoda; Hisayoshi Oka
Journal:  J Neurol       Date:  2015-05-19       Impact factor: 4.849

5.  Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease.

Authors:  Hisayoshi Oka; Chizuko Toyoda; Makiko Yogo; Soichiro Mochio
Journal:  J Neural Transm (Vienna)       Date:  2011-02-18       Impact factor: 3.575

Review 6.  123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation.

Authors:  Paola Gargiulo; Wanda Acampa; Gaetano Asile; Vincenza Abbate; Ermanno Nardi; Federica Marzano; Roberta Assante; Carmela Nappi; Antonio Luca Maria Parlati; Christian Basile; Santo Dellegrottaglie; Stefania Paolillo; Alberto Cuocolo; Pasquale Perrone-Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-08       Impact factor: 10.057

Review 7.  Sympathetic neuroimaging.

Authors:  David S Goldstein
Journal:  Handb Clin Neurol       Date:  2013

Review 8.  (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.

Authors:  Eun Joo Chung; Sang Jin Kim
Journal:  J Mov Disord       Date:  2015-05-31

9.  Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease.

Authors:  Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado
Journal:  Clin Auton Res       Date:  2021-07-12       Impact factor: 4.435

10.  Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Authors:  Eva Stuebner; Ekawat Vichayanrat; David A Low; Christopher J Mathias; Stefan Isenmann; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.